FIG. 6.
In vivo bioluminescence monitoring of EC14(pCGLS1.UC) in the neutropenic-mouse thigh model of infection using the ICCD camera. Each data point is the mean ± SE of the same four animals at each time point. Viable counts are indicated for 0- and 12-h time points for both the untreated infection control group and the ceftazidime treated group. IC, infection control; CAZ, ceftazidime treatment (50 mg/kg at 1 and 5 h postinfection).